Literature DB >> 16732168

Oseltamivir and delirious behavior in children with influenza.

Akihisa Okumura, Tetsuo Kubota, Toru Kato, Tsuneo Morishima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16732168     DOI： 10.1097/01.inf.0000219363.24938.62

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  11 in total

Review 1.  Influenza vaccination and treatment in children with neurologic disorders.

Authors:  Fiona Havers; Alicia Fry; Georgina Peacock; Lyn Finelli
Journal:  Ther Adv Vaccines       Date:  2014-07

2.  Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.

Authors:  S S Jhee; M Yen; L Ereshefsky; M Leibowitz; M Schulte; B Kaeser; L Boak; A Patel; G Hoffmann; E P Prinssen; C R Rayner
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

3.  The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.

Authors:  William A Blumentals; Xue Song
Journal:  MedGenMed       Date:  2007-10-30

4.  In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu) and active metabolite.

Authors:  Lothar Lindemann; Helmut Jacobsen; Diana Schuhbauer; Frederic Knoflach; Silvia Gatti; Joseph G Wettstein; Hansruedi Loetscher; Tom Chu; Martin Ebeling; James C Paulson; Eric Prinssen; Manfred Brockhaus
Journal:  Eur J Pharmacol       Date:  2009-11-14       Impact factor: 4.432

Review 5.  Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Authors:  Stephen Toovey; Craig Rayner; Eric Prinssen; Tom Chu; Barbara Donner; Bharat Thakrar; Regina Dutkowski; Gerhard Hoffmann; Alexander Breidenbach; Lothar Lindemann; Ellen Carey; Lauren Boak; Ronald Gieschke; Susan Sacks; Jonathan Solsky; Ian Small; David Reddy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.

Authors:  Gerhard Hoffmann; Christoph Funk; Stephen Fowler; Michael B Otteneder; Alexander Breidenbach; Craig R Rayner; Tom Chu; Eric P Prinssen
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

7.  Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.

Authors:  T Anekthananon; S Pukrittayakamee; S Pukritayakamee; W Ratanasuwan; P Jittamala; P Werarak; P Charunwatthana; S Suwanagool; S Lawpoolsri; K Stepniewska; P Sapchookul; P Puthavathana; C Fukuda; N Lindegardh; J Tarning; N J White; N Day; W R J Taylor
Journal:  J Antimicrob Chemother       Date:  2012-11-09       Impact factor: 5.790

8.  Oseltamivir (tamiflu) induced depressive episode in a female adolescent.

Authors:  Sungho Chung; Yoo Sook Joung
Journal:  Psychiatry Investig       Date:  2010-11-11       Impact factor: 2.505

9.  Evaluation of [(11)C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infection.

Authors:  Chie Seki; Arata Oh-Nishi; Yuji Nagai; Takafumi Minamimoto; Shigeru Obayashi; Makoto Higuchi; Makoto Takei; Kenji Furutsuka; Takehito Ito; Ming-Rong Zhang; Hiroshi Ito; Mototsugu Ito; Sumito Ito; Hiroyuki Kusuhara; Yuichi Sugiyama; Tetsuya Suhara
Journal:  EJNMMI Res       Date:  2014-07-02       Impact factor: 3.138

10.  Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.

Authors:  Maryna C Eichelberger; Arash Hassantoufighi; Meng Wu; Min Li
Journal:  Virol J       Date:  2008-09-26       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.